PAVmed reports Q4 2025 results, strengthens capital structure
Go back to PAVmed reports Q4 2025 results, strengthens capital structure| (NASDAQ: LUCD) | Delayed: 1.08 +0.10 (10.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.98 | 52 Week High | $ | |||
| Open | $1.00 | 52 Week Low | $ | |||
| Day High | $1.08 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 6,013,154 | |||||
| (NASDAQ: PAVM) | Delayed: 5.16 +0.16 (3.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.00 | 52 Week High | $15.24 | |||
| Open | $5.00 | 52 Week Low | $10.50 | |||
| Day High | $5.19 | P/E | N/A | |||
| Day Low | $3.85 | EPS | $0.00 | |||
| Volume | 208,426 | |||||
